The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Amgen; Boehringer Ingelheim; Celgene; ImClone Systems; Ipsen; Keocyt; Merck Serono; Novartis; Roche; Sanofi; Teva
Sunitinib as second-line treatment in patients with advanced intrahepatic cholangiocarcinoma (SUN-CK phase II trial): Safety, efficacy, and updated translational results.
 
Cindy Neuzillet
No Relationships to Disclose
 
Jean-François Seitz
Honoraria - Amgen; Bayer Schering Pharma; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
 
Laetitia Fartoux
Honoraria - Bayer Schering Pharma; Bristol-Myers Squibb
 
David Malka
No Relationships to Disclose
 
Gérard Lledo
No Relationships to Disclose
 
Annemilai Tijeras-Raballand
No Relationships to Disclose
 
Armand De Gramont
No Relationships to Disclose
 
Maxime Ronot
No Relationships to Disclose
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
 
Chantal Dreyer
No Relationships to Disclose
 
Alexandre Amin
No Relationships to Disclose
 
Philippe Brunisholz - Bourget
No Relationships to Disclose
 
Alexandra Hadengue
No Relationships to Disclose
 
Nelly Roldan
No Relationships to Disclose
 
Benoist Chibaudel
No Relationships to Disclose
 
Eric Raymond
Honoraria - Bayer Schering Pharma; Novartis; Pfizer
 
Sandrine J. Faivre
Honoraria - Bayer Schering Pharma; Novartis; Pfizer